|
Vasoconstrictor |
|
Vasodilator |
|
|
|
|
1) |
S2
receptor: Director activation of
vascular |
1) |
S1
Receptor: Activation of |
|
smooth
muscle. |
|
endothelial
cells which release |
|
|
|
endothelial
relaxing factors. |
|
|
|
|
2) |
Release
of norepinephrine from |
2) |
S1
receptor: Inhibition of |
|
adrenergic
nerves. |
|
adrenergic
neurotransmission |
|
|
|
via
action on prejunctional |
|
|
|
receptors. |
|
|
|
|
3) |
Augmentation
of other endogenous |
3) |
Release
of other endogenous |
|
vasoconstrictors. |
|
mediators. |
|
|
|
|
|
|
4) |
Direct
inhibition of vascular |
|
|
|
smooth
muscle. |
(Adapted
from Reference 87)
published 2000